Literature DB >> 27849576

Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage.

Sarah J Hill1,2,3, Daniel A Mordes4,5,6, Lisa A Cameron7, Donna S Neuberg8, Serena Landini2,3,9, Kevin Eggan4,6, David M Livingston10,3,9.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron dysfunction disease that leads to paralysis and death. There is currently no established molecular pathogenesis pathway. Multiple proteins involved in RNA processing are linked to ALS, including FUS and TDP43, and we propose a disease mechanism in which loss of function of at least one of these proteins leads to an accumulation of transcription-associated DNA damage contributing to motor neuron cell death and progressive neurological symptoms. In support of this hypothesis, we find that FUS or TDP43 depletion leads to increased sensitivity to a transcription-arresting agent due to increased DNA damage. Thus, these proteins normally contribute to the prevention or repair of transcription-associated DNA damage. In addition, both FUS and TDP43 colocalize with active RNA polymerase II at sites of DNA damage along with the DNA damage repair protein, BRCA1, and FUS and TDP43 participate in the prevention or repair of R loop-associated DNA damage, a manifestation of aberrant transcription and/or RNA processing. Gaining a better understanding of the role(s) that FUS and TDP43 play in transcription-associated DNA damage could shed light on the mechanisms underlying ALS pathogenesis.

Entities:  

Keywords:  ALS; DNA damage response; R loop; transcription

Mesh:

Substances:

Year:  2016        PMID: 27849576      PMCID: PMC5137757          DOI: 10.1073/pnas.1611673113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Accelerated high-yield generation of limb-innervating motor neurons from human stem cells.

Authors:  Mackenzie W Amoroso; Gist F Croft; Damian J Williams; Sean O'Keeffe; Monica A Carrasco; Anne R Davis; Laurent Roybon; Derek H Oakley; Tom Maniatis; Christopher E Henderson; Hynek Wichterle
Journal:  J Neurosci       Date:  2013-01-09       Impact factor: 6.167

2.  ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects.

Authors:  Haiyan Qiu; Sebum Lee; Yulei Shang; Wen-Yuan Wang; Kin Fai Au; Sherry Kamiya; Sami J Barmada; Steven Finkbeiner; Hansen Lui; Caitlin E Carlton; Amy A Tang; Michael C Oldham; Hejia Wang; James Shorter; Anthony J Filiano; Erik D Roberson; Warren G Tourtellotte; Bin Chen; Li-Huei Tsai; Eric J Huang
Journal:  J Clin Invest       Date:  2014-02-10       Impact factor: 14.808

3.  Location of BRCA1 in human breast and ovarian cancer cells.

Authors:  R Scully; S Ganesan; M Brown; J A De Caprio; S A Cannistra; J Feunteun; S Schnitt; D M Livingston
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

Review 4.  Repetitive head trauma, chronic traumatic encephalopathy and tau: Challenges in translating from mice to men.

Authors:  Joseph O Ojo; Benoit C Mouzon; Fiona Crawford
Journal:  Exp Neurol       Date:  2015-06-06       Impact factor: 5.330

Review 5.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

6.  FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2.

Authors:  Jacob C Schwartz; Christopher C Ebmeier; Elaine R Podell; Joseph Heimiller; Dylan J Taatjes; Thomas R Cech
Journal:  Genes Dev       Date:  2012-12-15       Impact factor: 11.361

7.  ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function.

Authors:  Tetsuro Murakami; Seema Qamar; Julie Qiaojin Lin; Gabriele S Kaminski Schierle; Eric Rees; Akinori Miyashita; Ana R Costa; Roger B Dodd; Fiona T S Chan; Claire H Michel; Deborah Kronenberg-Versteeg; Yi Li; Seung-Pil Yang; Yosuke Wakutani; William Meadows; Rodylyn Rose Ferry; Liang Dong; Gian Gaetano Tartaglia; Giorgio Favrin; Wen-Lang Lin; Dennis W Dickson; Mei Zhen; David Ron; Gerold Schmitt-Ulms; Paul E Fraser; Neil A Shneider; Christine Holt; Michele Vendruscolo; Clemens F Kaminski; Peter St George-Hyslop
Journal:  Neuron       Date:  2015-10-29       Impact factor: 17.173

8.  PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS/TLS to sites of oxidative DNA damage.

Authors:  Stuart L Rulten; Amy Rotheray; Ryan L Green; Gabrielle J Grundy; Duncan A Q Moore; Fernando Gómez-Herreros; Majid Hafezparast; Keith W Caldecott
Journal:  Nucleic Acids Res       Date:  2013-09-18       Impact factor: 16.971

Review 9.  Functions of FUS/TLS from DNA repair to stress response: implications for ALS.

Authors:  Reddy Ranjith Kumar Sama; Catherine L Ward; Daryl A Bosco
Journal:  ASN Neuro       Date:  2014-06-01       Impact factor: 4.146

10.  FUS is sequestered in nuclear aggregates in ALS patient fibroblasts.

Authors:  Jacob C Schwartz; Elaine R Podell; Steve S W Han; James D Berry; Kevin C Eggan; Thomas R Cech
Journal:  Mol Biol Cell       Date:  2014-07-09       Impact factor: 4.138

View more
  51 in total

Review 1.  Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease.

Authors:  Seth A Bennett; Royena Tanaz; Samantha N Cobos; Mariana P Torrente
Journal:  Transl Res       Date:  2018-10-12       Impact factor: 7.012

2.  Motor neurons from ALS patients with mutations in C9ORF72 and SOD1 exhibit distinct transcriptional landscapes.

Authors:  Ching-On Wong; Kartik Venkatachalam
Journal:  Hum Mol Genet       Date:  2019-08-15       Impact factor: 6.150

3.  SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage.

Authors:  Mohini Jangi; Christina Fleet; Patrick Cullen; Shipra V Gupta; Shila Mekhoubad; Eric Chiao; Norm Allaire; C Frank Bennett; Frank Rigo; Adrian R Krainer; Jessica A Hurt; John P Carulli; John F Staropoli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-07       Impact factor: 11.205

Review 4.  Poly(ADP-Ribosylation) in Age-Related Neurological Disease.

Authors:  Leeanne McGurk; Olivia M Rifai; Nancy M Bonini
Journal:  Trends Genet       Date:  2019-06-07       Impact factor: 11.639

5.  The Glycoside Oleandrin Reduces Glioma Growth with Direct and Indirect Effects on Tumor Cells.

Authors:  Stefano Garofalo; Alfonso Grimaldi; Giuseppina Chece; Alessandra Porzia; Stefania Morrone; Fabrizio Mainiero; Giuseppina D'Alessandro; Vincenzo Esposito; Barbara Cortese; Silvia Di Angelantonio; Flavia Trettel; Cristina Limatola
Journal:  J Neurosci       Date:  2017-03-14       Impact factor: 6.167

6.  Nol12 is a multifunctional RNA binding protein at the nexus of RNA and DNA metabolism.

Authors:  Daniel D Scott; Christian Trahan; Pierre J Zindy; Lisbeth C Aguilar; Marc Y Delubac; Eric L Van Nostrand; Srivathsan Adivarahan; Karen E Wei; Gene W Yeo; Daniel Zenklusen; Marlene Oeffinger
Journal:  Nucleic Acids Res       Date:  2017-12-01       Impact factor: 16.971

Review 7.  Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Authors:  Zongbing Hao; Rui Wang; Haigang Ren; Guanghui Wang
Journal:  Neurosci Bull       Date:  2020-08-29       Impact factor: 5.203

8.  The Gypsy Endogenous Retrovirus Drives Non-Cell-Autonomous Propagation in a Drosophila TDP-43 Model of Neurodegeneration.

Authors:  Yung-Heng Chang; Josh Dubnau
Journal:  Curr Biol       Date:  2019-09-05       Impact factor: 10.834

Review 9.  Transcribing malignancy: transcription-associated genomic instability in cancer.

Authors:  B Boulianne; N Feldhahn
Journal:  Oncogene       Date:  2017-11-06       Impact factor: 9.867

10.  Meta-analysis of Genetic Modifiers Reveals Candidate Dysregulated Pathways in Amyotrophic Lateral Sclerosis.

Authors:  Katherine S Yanagi; Zhijin Wu; Joshua Amaya; Natalie Chapkis; Amanda M Duffy; Kaitlyn H Hajdarovic; Aaron Held; Arjun D Mathur; Kathryn Russo; Veronica H Ryan; Beatrice L Steinert; Joshua P Whitt; Justin R Fallon; Nicolas L Fawzi; Diane Lipscombe; Robert A Reenan; Kristi A Wharton; Anne C Hart
Journal:  Neuroscience       Date:  2019-01-01       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.